Morten Haugen/LinkedIn
Sep 19, 2025, 16:48
Morten Haugen Warns of IgG Risks for High-Frequency Plasma Donors
Morten Haugen, Resident physician specializing in immunology and transfusion medicine at Oslo University Hospital, shared a post on LinkedIn:
“New evidence on plasma donation frequency:
- The first paper from my PhD-work is now published in Vox Sanguinis! In this randomized trial we found that
High-frequency (3×/2 weeks) and regular-frequency (1×/2 weeks) plasma donation significantly lowered total serum protein and immunoglobulin G. - Up to 26% of high-frequency donors dropped below the IgG safety threshold of 6.0 g/L, even when starting with normal levels of more than 8.0 g/L in most donors.
- Many plasma proteins had not recovered 4 weeks after the last donation.
These findings highlight the need for careful donor monitoring and further research into long-term health effects.
Full article here

Thanks to the volunteer blood donors, the research team and my co-authors Karin Magnussen, Tor Strand and Lise Sofie Nissen-Meyer for making the study possible.”
Stay updated with Hemostasis Today.
-
Jul 27, 2026, 04:50A Significant Step Forward for People with Bleeding Disorders in the Dominican Republic – WFH
-
Jul 27, 2026, 04:11Mohamed F Doheim: Clarifying the Role of Late IV Thrombolysis in the Era of Endovascular Therapy
-
Jul 27, 2026, 03:50Françoise Dignat-George: The Rising Impact of Extracellular Vesicles Spotlighted at ISTH 2026
-
Jul 27, 2026, 03:42Koson Tony Sriamporn: A Milestone for Inclusive Blood Donor Eligibility
-
Jul 27, 2026, 03:34Wolfgang Miesbach: A Standout Talk by Jeffrey Weitz at ISTH 2026
-
Jul 26, 2026, 23:18Mohammadmahdi Sabahi: Proud to Share Our Complete Cushing’s Disease Research Collection
-
Jul 26, 2026, 22:59Mahmood Naseri: The Results of the 2nd Clinical Trial on AriClot Are Now Live in Burns Journal
-
Jul 26, 2026, 16:26Novi Yanti Sari: When MPNs Affect the Heart
-
Jul 26, 2026, 16:21Beyond Drugs: Can Museums Become a Medical Prescription?